Jacqueline Sybil Papkoff's Net Worth
$95.7 Thousand
Who is Jacqueline Sybil Papkoff?
Jacqueline Sybil Papkoff does not have any significant net worth to report based on the numbers we have. This is based on reported shares in ASSEMBLY BIOSCIENCES, INC..
SEC CIK
Jacqueline Sybil Papkoff's CIK is 0001735729
Past Insider Trading and Trends
2018 was Jacqueline Sybil Papkoff's most active year for acquiring shares with 3 total transactions. Jacqueline Sybil Papkoff's most active month to acquire stocks was the month of February. 2020 was Jacqueline Sybil Papkoff's most active year for disposing of shares, totalling 2 transactions. Jacqueline Sybil Papkoff's most active month to dispose stocks was the month of November. 2018 saw Jacqueline Sybil Papkoff paying a total of $0.00 for 138,075 shares, this is the most they've acquired in one year. In 2019 Jacqueline Sybil Papkoff cashed out on 1,460 shares for a total of $30,661.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ASSEMBLY BIOSCIENCES, INC. (ASMB) Snapshot price: $1.05
SVP-CSO Microbiome
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.35% | -1.30K |
$6.15 | -$7,982.78 | 37.36K |
Scheduled
|
Dec 14
| ||
Form 4
| +68.71% | 15.75K |
$14.22 | -$17,830.88 | 38.66K |
Scheduled
|
Mar 27 - Mar 30
| ||
Form 4
| -5.99% | -1.46K |
$21.00 | -$30,661.61 | 22.91K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
| +129.41% | 13.75K |
—
|
—
| 24.38K |
Mar 29
| |||
Form 4
|
∞
| 10.63K |
—
|
—
| 10.63K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||